SYNERGEN Health Recognized with Five Consecutive Great Place to Work® Accolades in 2022
SYNERGEN named as '10 Best Workplaces in the IT & ITES Industry in Sri Lanka,' '50 Best WorkplacesTM in Sri Lanka,' '70 Large Best Workplaces in AsiaTM,' '15 Best WorkplacesTM for Millennials in Sri Lanka' and '15 Best Workplaces for Women in Sri Lanka' DALLAS and COLOMBO, Sri Lanka, Oct. 5, 2022...
Ascletis Announces Dosing of the First Patient in Phase II Clinical Trial of THRβ Agonist ASC41 for 52-Week Treatment of Liver Biopsy-Proven NASH
-- ASC41 is ranking first in China and third in the world in terms of clinical progress as a thyroid hormone receptor β (THRβ) agonist drug candidate for non-alcoholic steatohepatitis (NASH). ASC41 Phase II clinical trial is currently the most advanced 52-week Phase II clinical trial which is initiated by a China biotech company with enrollment of liver...
Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting Antibody TST004 for the Treatment of IgA Nephropathy
SUZHOU, China, Oct. 5, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that TST004, its best-in-class, humanized monoclonal antibody targeting MASP2, has received IND clearance from U.S. Food and Drug Administration (FDA). MASP2, mannose-binding protein-associated serine protease 2, is a...
HAVAS HEALTH & YOU APPOINTS PAUL PFLEIDERER AS PRESIDENT OF HAVAS LIFE NEW YORK
NEW YORK, Oct. 4, 2022 /PRNewswire/ -- As the rapid evolution of the health and wellness sector continues to necessitate innovative thinking and activation across the industry, Havas Health & You today announced that it has appointed seasoned strategic leader Paul Pfleiderer as President of Havas Life New York. Paul joined Havas Life...
IMG Appoints Amanda Winkle as Chief Operating Officer
INDIANAPOLIS, Oct. 4, 2022 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning global insurance benefits and assistance services company, is pleased to announce that Amanda Winkle, formerly the Chief Commercial Officer, has been appointed as Chief Operating Officer. In this role, Amanda will oversee the commercial, information technology, and operations functions of...
RevitaLash® Cosmetics Champions Breast Cancer Awareness, Research, and Support Worldwide with 2022 Pink Program Announcement
The Mission-Driven Lash & Brow Leader Expands Its Year-Round Breast Cancer Awareness Efforts Globally VENTURA, Calif., Oct. 4, 2022 /PRNewswire/ -- RevitaLash® Cosmetics is proud to announce the company's annual 2022 Pink Program campaign. In honor of Breast Cancer Awareness month, RevitaLash® Cosmetics is launching new activations and supporting existing initiatives, including limited-edition product offerings that...
HanAll’s Second FcRn Inhibitor HL161ANS to be Added to the Development Program of its Licensed Partner
Immunovant, a HanAll's licensed partner, unveiled its plan to develop a new FcRn inhibitor, HL161ANS (also known as IMVT-1402) In animal studies, HL161ANS indicated deep IgG reductions similar to batoclimab with no or minimal impact on albumin and LDL cholesterol level Batoclimab (formerly known as HL161BKN) and HL161ANS originated from HanAll....
GHA’s HealthStars EXCELerator: Driving Business and Healthcare Outcomes through Innovation
WEST PALM BEACH, Fla., Oct. 4, 2022 /PRNewswire/ -- Global Healthcare Accreditation (GHA) announces the launch of HealthStars EXCELerator, a program designed to accelerate innovation and maximize a businesses' opportunity for success in the global healthcare space. In healthcare, the goal is to provide greater access to care, greater quality of care, and improved patient experience....
Pacertool Establishes World-Class Scientific Advisory Board
The Scientific Advisory Board Will Develop the Company Clinical Trial Strategy, Ensure Alignment with Current Trends in Cardiac Pacing for Heart Failure Patients and Provide Input to the Pacertool Innovation Pipeline. OSLO, Norway, Oct. 4, 2022 /PRNewswire/ -- Pacertool AS, a Norwegian emerging medical device company, today announced that the company has established a world-class Scientific Advisory Board (SAB), which is...
Cambrex Announces Stability Storage Expansions in Ireland and Belgium
EAST RUTHERFORD, NJ, Oct. 4, 2022 /PRNewswire/ -- Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. Q1 Scientific will open a new 20,000-square-foot cGMP facility in Belgium and add an additional 10,000 square...
